Email this article Safety of lipid-lowering pharmacotherapy in elderly patients with stable angina
- Authors: Gagloeva IV1
-
Affiliations:
- Issue: Vol 10, No 7-8 (2010)
- Pages: 12-15
- Section: Articles
- URL: https://aspvestnik.ru/2410-3764/article/view/25118
- DOI: https://doi.org/10.17816/2072-2354.2010.0.7-8.12-15
- ID: 25118
Cite item
Full Text
Abstract
We estimated the safety of lipid-lowering pharmacotherapy in 248 elderly patients with stable angina. Rosuvastatin 10 mg/day with esetemib 10 mg/day was administrated to 81 pts of Group 1 with initial high LDL-level. Combination of atorvastatin 20 mg/day with esetemib 10 mg/day was administrated to 84 pts of Group 2 with moderate high LDL-level, while 83 pts of Group 3 with optimal LDL-level received simvastatin 40 mg/day. After 12 months of follow-up period we registered myalgia and/or myasthenia in 6 pts (2,4%), dyspepsia in 11 pts (4,4%) and increasing of transaminases in 9 pts (3,6%). In consideration of clinical significant events we interrupted the course of treatment in 4 pts (1,6%). The main causes among them were severe myalgia and/or myasthenia in 1 pt (0,4%), dyspepsia and gastrointestinal disorders in 3 pts (1,2%).
References
- Демографический ежегодник России. 2008: стат. сб. - M.: Росстат, 2008. - 557 c.
- Кухарчук В.В. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. // Российские рекомендации III пересмотр 2007. Эксперты ВНОК. Секция атеросклероза. Москва. 2007.
- Sidney C.S., Jerilyn A., Steven N.B. AHA/ACC Guidelines for Secondary Prevention for Patients with Coronary and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute / // Circulation. - 2006. - № 113. - Р. 2363-2372.
- Heart Protection Study (HPS) Collaborative Group / MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 5963 people with diabetes // Lancet. - 2003. - Vol. 361, № 14. - P. 2005-2016.
- Pasternak RC, Smith SCJr, Bairey-Merz CN et al ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 2002; 40: 567-72.
- Hendel, R. C. ACCF/ACR/SCCT/SCMR/ ASNC/NASCI/SCAI/SIR Appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging / R. C. Hendel et al. // J. Am. Coll. Cardiol. - 2006. - Vol. 48, № 7. - P. 1475-1497.
- Kastelein, J. Simvastatin with or without ezetimibe in familial hypercholesterolaemia / J. Kastelein, F. Akdim et al. // New Engl. J. Med. - 2008. - Vol. 358. - P. 1431-1443.
- Joint ISA - National LIPID (NLA) Symposium Report of the TASK FORCE ON SТATIN SAFEТY. Atherosclerosis 2006; 7(3): 1-2.
Supplementary files
